PVG Asset Management’s Immix Biopharma IMMX Stock Holding History

PVG Asset Management’s Portfolio IMMX Stock Details IMMX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$71.2K	Buy	+20,000	New	+$68.4K	0.26%	41

Other funds holding IMMX

Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

LCM

Lynwood Capital Management Toronto, Ontario, Canada $16.9M AUM 19.31% 1-Year Est. Return

ACM

Altium Capital Management New York $42M AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

EVC

Eidelman Virant Capital Saint Louis, Missouri $136M AUM 15.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

PVG Asset Management's IMMX Position: Q4 2021 in Review

PVG Asset Management opened a new position in Immix Biopharma (IMMX) in Q4 2021: 20,000 shares worth $71.2K. The stake represents 0.26% of the portfolio and ranks #41 among its holdings.

11 funds tracked by Wall St. Rank hold IMMX as of Q4 2021.

PVG Asset Management held 20,000 shares of Immix Biopharma worth $71.2K as of Q4 2021.
Immix Biopharma was a new PVG Asset Management position in Q4 2021.
Immix Biopharma made up 0.26% of PVG Asset Management's portfolio in Q4 2021, its #41 holding.
11 funds tracked by Wall St. Rank held Immix Biopharma as of Q4 2021.

Based on PVG Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.